Original Article
Neuropsychopharmacology (2005) 30, 1269–1277, advance online publication, 9 February 2005; doi:10.1038/sj.npp.1300686
Preclinical Research
Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain
Mostafa El Mansari1,3, Connie Sánchez2, Guy Chouvet1, Bernard Renaud1 and Nasser Haddjeri1
- 1Laboratory of Neuropharmacology and Neurochemistry, Faculty of Pharmacy, University of Claude Bernard Lyon I, Lyon Cedex, France
- 2Neuropharmacological Research, H Lundbeck A/S, Valby, Denmark
Correspondence: Dr N Haddjeri, Laboratory of Neuropharmacology and Neurochemistry, Faculty of Pharmacy, Claude Bernard University, INSERM U-512, 8, Avenue Rockefeller, 69373 Lyon Cedex 08, France. Tel: +33 4 78 77 75 54; Fax: +33 4 78 77 72 09; E-mail: nhaddj@rockefeller.univ-lyon1.fr
3Present address: Institute of Mental Health Research, University of Ottawa, Lady Grey Bldg, 1145 Carling Avenue, Ottawa, Ontario, Canada K17 7K4.
Received 20 August 2004; Revised 20 December 2004; Accepted 21 December 2004; Published online 9 February 2005.
Abstract
The present study was undertaken to compare the acute and long-term effects of escitalopram and citalopram on rat brain 5-HT neurotransmission, using electrophysiological techniques. In hippocampus, after 2 weeks of treatment with escitalopram (10 mg/kg/day, s.c.) or citalopram (20 mg/kg/day, s.c.), the administration of the selective 5-HT1A receptor antagonist WAY-100,635 (20–100
g/kg, i.v.) dose-dependently induced a similar increase in the firing activity of dorsal hippocampus CA3 pyramidal neurons, thus revealing direct functional evidence of an enhanced tonic activation of postsynaptic 5-HT1A receptors. In dorsal raphe nucleus, escitalopram was four times more potent than citalopram in suppressing the firing activity of presumed 5-HT neurons (ED50=58 and 254
g/kg, i.v., respectively). Interestingly, the suppressant effect of escitalopram (100
g/kg, i.v.) was significantly prevented, but not reversed by R-citalopram (250
g/kg, i.v.). Sustained administration of escitalopram and citalopram significantly decreased the spontaneous firing activity of presumed 5-HT neurons. This firing activity returned to control rate after 2 weeks in rats treated with escitalopram, but only after 3 weeks using citalopram, and was associated with a desensitization of somatodendritic 5-HT1A autoreceptors. These results suggest that the time course of the gradual return of presumed 5-HT neuronal firing activity, which was reported to account for the delayed effect of SSRI on 5-HT transmission, is congruent with the earlier onset of action of escitalopram vs citalopram in validated animal models of depression and anxiety.
Keywords:
escitalopram, citalopram, 5-HT, dorsal raphe, hippocampus, 5-HT1A receptors
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Augmentation of SSRI Effects on Serotonin by 5-HT2C Antagonists: Mechanistic Studies
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article

